文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛儿科与产科急症

耐甲氧西林金黄色葡萄球菌脓毒症诱导凝血病、弥漫性微血管血栓形成及器官损伤的幼猪模型

Pediatric Swine Model of Methicillin-Resistant Staphylococcus aureus Sepsis-Induced Coagulopathy, Disseminated Microvascular Thrombosis, and Organ Injuries.
PubMed 文献 · Crit Care Explor · 2023-05-26
一句话结论研究建立70小时3周龄幼猪MRSA脓毒症模型,24小时内出现神经与呼吸评分显著降低,凝血病、微血管血栓及早期局灶器官损伤,可用于研究宿主免疫失调与凝血病并测试新疗法。

为建立模拟儿童脓毒症诱导凝血病的大动物模型,研究者将10只3周龄幼猪植入遥测装置后随机静脉注射MRSA(USA300,Texas Children's Hospital 1516株,1×10^9 CFU/kg,n=6)或生理盐水(n=4),按心率较基线升高>50%或平均动脉压较基线降低>30%给予液体复苏,必要时给对乙酰氨基酚和葡萄糖,于注射前及0、24、48、60、70小时行床旁血常规、PT、活化凝血活酶时间、D-二聚体、纤维蛋白原及专门凝血检测。结果显示脓毒症幼猪24小时内神经和呼吸评分显著低于对照,PT、D-二聚体、纤维蛋白原随时间升高,血小板计数及因子V、VII、蛋白C、抗凝血酶、ADAMTS-13活性显著降低,组织病理见肾脏和肝脏微血管血栓与坏死等轻微局灶器官损伤。作者认为该70小时模型与儿童脓毒症临床相关,可用于研究宿主免疫失调与感染相关凝血病、识别早期生物标志物及测试新疗法。

要点

  • 3周龄幼猪静脉注射MRSA USA300(Texas Children's Hospital 1516株)1×10^9 CFU/kg可建立持续70小时的脓毒症诱导凝血病模型。
  • 脓毒症幼猪24小时内神经和呼吸评分显著低于生理盐水对照,提示早期神经与呼吸功能恶化。
  • 脓毒症幼猪PT、D-二聚体、纤维蛋白原随时间升高,血小板计数及因子V、VII、蛋白C、抗凝血酶、ADAMTS-13活性显著降低。
  • 组织病理显示脓毒症幼猪肾脏和肝脏微血管血栓与坏死,属轻微局灶器官损伤。
  • 作者认为该模型与儿童脓毒症临床相关,可用于研究宿主免疫失调与凝血病、识别早期生物标志物及测试新疗法。

适用人群与场景

  • 3周龄幼猪,植入遥测装置连续血流动力学监测,静脉注射MRSA(USA300,Texas Children's Hospital 1516株)1×10^9 CFU/kg(n=6)或生理盐水(n=4)。
  • 心率较基线升高>50%或平均动脉压较基线降低>30%时给予液体复苏,必要时给对乙酰氨基酚和葡萄糖。

处置流程与药物剂量

  • 静脉注射MRSA USA300(Texas Children's Hospital 1516株)1×10^9 CFU/kg建立脓毒症模型。
  • 心率较基线升高>50%或平均动脉压较基线降低>30%时给予液体复苏。
  • 必要时给予对乙酰氨基酚和葡萄糖。
  • 于注射前及注射后0、24、48、60、70小时行床旁血常规、PT、活化凝血活酶时间、D-二聚体、纤维蛋白原及专门凝血检测。
  • 实验结束时安乐死幼猪并行尸检。

研究设计与关键结果

  • 研究类型为幼猪脓毒症模型实验,共10只3周龄幼猪,MRSA组n=6、生理盐水对照组n=4。
  • 与生理盐水对照相比,脓毒症幼猪24小时内神经和呼吸评分显著降低。
  • 随时间推移,脓毒症幼猪PT、D-二聚体、纤维蛋白原较对照升高,血小板计数及因子V、VII、蛋白C、抗凝血酶、ADAMTS-13活性较对照显著降低。
  • 组织病理检查显示脓毒症幼猪肾脏和肝脏微血管血栓与坏死,为轻微局灶器官损伤。

证据类型、等级与局限

  • 证据类型:动物实验(幼猪脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该70小时幼猪模型与儿童脓毒症临床相关,可用于研究宿主免疫失调与感染相关凝血病、识别潜在早期生物标志物及测试新疗法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Sepsis-induced coagulopathy leading to disseminated microvascular thrombosis is associated with high mortality and has no existing therapy. Despite the high prevalence of Gram-positive bacterial sepsis, especially methicillin-resistant Staphylococcus aureus (MRSA), there is a paucity of published Gram-positive pediatric sepsis models. Large animal models replicating sepsis-induced coagulopathy are needed to test new therapeutics before human clinical trials.

HYPOTHESIS: Our objective is to develop a pediatric sepsis-induced coagulopathy swine model that last 70 hours.

METHODS AND MODELS: Ten 3 weeks old piglets, implanted with telemetry devices for continuous hemodynamic monitoring, were IV injected with MRSA (n = 6) (USA300, Texas Children's Hospital 1516 strain) at 1 × 109 colony forming units/kg or saline (n = 4). Fluid resuscitation was given for heart rate greater than 50% or mean arterial blood pressure less than 30% from baseline. Acetaminophen and dextrose were provided as indicated. Point-of-care complete blood count, prothrombin time (PT), activated thromboplastin time, d-dimer, fibrinogen, and specialized coagulation assays were performed at pre- and post-injection, at 0, 24, 48, 60, and 70 hours. Piglets were euthanized and necropsies performed.

RESULTS: Compared with the saline treated piglets (control), the septic piglets within 24 hours had significantly lower neurologic and respiratory scores. Over time, PT, d-dimer, and fibrinogen increased, while platelet counts and activities of factors V, VII, protein C, antithrombin, and a disintegrin and metalloproteinase with thrombospondin-1 motifs (13th member of the family) (ADAMTS-13) decreased significantly in septic piglets compared with control. Histopathologic examination showed minor focal organ injuries including microvascular thrombi and necrosis in the kidney and liver of septic piglets.

INTERPRETATIONS AND CONCLUSIONS: We established a 70-hour swine model of MRSA sepsis-induced coagulopathy with signs of consumptive coagulopathy, disseminated microvascular thrombosis, and early organ injuries with histological minor focal organ injuries. This model is clinically relevant to pediatric sepsis and can be used to study dysregulated host immune response and coagulopathy to infection, identify potential early biomarkers, and to test new therapeutics.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Nguyen TC, Marini JC, Guillory B, et al. Pediatric Swine Model of Methicillin-Resistant Staphylococcus aureus Sepsis-Induced Coagulopathy, Disseminated Microvascular Thrombosis, and Organ Injuries. Crit Care Explor. 2023. PMID: 37255626. doi:10.1097/CCE.0000000000000916

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。